50 million or so ? everything is priced in for complete failure...... No other reason for market cap to be this tiny...... If this had potential a big pharma or big biotech could buy it real cheap.... I keep dreaming of CYCC being a Billion dollar cap but i would have a better chance winning the power ball... good luck fellow dreamers..
My only concern is that there has been no partnership at this point of time. Of course perhaps they ae waiting to see additional data before approaching the company. You're right however about the pricing...however if the drug fails (results are not exceptional)....watch out below. This will become a 20 million dollar cap stock. And then of course comes the lawsuits....bla bla bla. However there is always that possibility that the results will be better than the market anticipates and the stock makes a new high. I think we'll have our answer to the billion dollar question within the next few weeks...GLTA
In the next few weeks? How do you figure? The pivitol phase 3 trial for AML isn't expected to end until mid next year. That's when we'll find out if this company is a success or failure. We still have a year to wait. In the meantime, we'll have occasional earlier trial results (like MDS data) that can push the stock up or down a little. It might fall to 4 bucks. It might go up to 6 or 7 bucks. But it's the phase 3 trial that means everything. When we get those final results next year, this will either be a 15 to 20 dollar stock or a penny stock.